These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 20055110

  • 1. Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery.
    Bi R, Shao W, Wang Q, Zhang N.
    J Biomed Nanotechnol; 2009 Feb; 5(1):84-92. PubMed ID: 20055110
    [Abstract] [Full Text] [Related]

  • 2. Biodegradable solid lipid nanoparticle flocculates for pulmonary delivery of insulin.
    Yang X, Liu Y, Liu C, Zhang N.
    J Biomed Nanotechnol; 2012 Oct; 8(5):834-42. PubMed ID: 22888755
    [Abstract] [Full Text] [Related]

  • 3. Solid lipid nanoparticles for pulmonary delivery of insulin.
    Liu J, Gong T, Fu H, Wang C, Wang X, Chen Q, Zhang Q, He Q, Zhang Z.
    Int J Pharm; 2008 May 22; 356(1-2):333-44. PubMed ID: 18281169
    [Abstract] [Full Text] [Related]

  • 4. Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery.
    Bi R, Shao W, Wang Q, Zhang N.
    J Drug Target; 2008 Nov 22; 16(9):639-48. PubMed ID: 18982512
    [Abstract] [Full Text] [Related]

  • 5. Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.
    Alsulays BB, Anwer MK, Soliman GA, Alshehri SM, Khafagy ES.
    Int J Nanomedicine; 2019 Nov 22; 14():9127-9138. PubMed ID: 31819423
    [Abstract] [Full Text] [Related]

  • 6. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y, Zhu J, Tang Y, Chen X, Yang Y.
    Drug Dev Ind Pharm; 2009 Sep 22; 35(9):1059-65. PubMed ID: 19640250
    [Abstract] [Full Text] [Related]

  • 7. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
    Al-Qadi S, Grenha A, Carrión-Recio D, Seijo B, Remuñán-López C.
    J Control Release; 2012 Feb 10; 157(3):383-90. PubMed ID: 21864592
    [Abstract] [Full Text] [Related]

  • 8. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang N, Ping Q, Huang G, Xu W, Cheng Y, Han X.
    Int J Pharm; 2006 Dec 11; 327(1-2):153-9. PubMed ID: 16935443
    [Abstract] [Full Text] [Related]

  • 9. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P, Yu T, Liu Y, Jiang J, Xu J, Zhao Y, Hao Y, Qiu Y, Zhao W, Wu C.
    Drug Des Devel Ther; 2016 Dec 11; 10():911-25. PubMed ID: 27041995
    [Abstract] [Full Text] [Related]

  • 10. [Development of Inhalable Dry Powder Formulations Loaded with Nanoparticles Maintaining Their Original Physical Properties and Functions].
    Okuda T.
    Yakugaku Zasshi; 2017 Dec 11; 137(11):1339-1348. PubMed ID: 29093369
    [Abstract] [Full Text] [Related]

  • 11. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM, Zhou L, Guo XD, Jiang W, Ling L, Qian Y, Luo KQ, Zhang LJ.
    Int J Pharm; 2012 Apr 04; 425(1-2):1-8. PubMed ID: 22248666
    [Abstract] [Full Text] [Related]

  • 12. Preparation, characterization, and pharmacodynamics of insulin-loaded fumaryl diketopiperazine microparticle dry powder inhalation.
    Xia Y, Su Y, Wang Q, Yang C, Tang B, Zhang Y, Tu J, Shen Y.
    Drug Deliv; 2019 Dec 04; 26(1):650-660. PubMed ID: 31257946
    [Abstract] [Full Text] [Related]

  • 13. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F, d'Emmanuele di Villa Bianca R, Giovino C, Miro A, Sorrentino R, Quaglia F, La Rotonda MI.
    J Control Release; 2009 Apr 02; 135(1):25-34. PubMed ID: 19154761
    [Abstract] [Full Text] [Related]

  • 14. Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats.
    Ansari MJ, Anwer MK, Jamil S, Al-Shdefat R, Ali BE, Ahmad MM, Ansari MN.
    Drug Deliv; 2016 Jul 02; 23(6):1972-9. PubMed ID: 26017100
    [Abstract] [Full Text] [Related]

  • 15. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N, Veerabrahma K.
    Drug Deliv; 2016 Jul 02; 23(2):395-404. PubMed ID: 24865287
    [Abstract] [Full Text] [Related]

  • 16. Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin.
    Zhang ZH, Zhang YL, Zhou JP, Lv HX.
    Int J Nanomedicine; 2012 Jul 02; 7():3333-9. PubMed ID: 22848162
    [Abstract] [Full Text] [Related]

  • 17. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang Z, Lv H, Zhou J.
    Pharmazie; 2009 Sep 02; 64(9):574-8. PubMed ID: 19827297
    [Abstract] [Full Text] [Related]

  • 18. Insulin-micro- and nanoparticles for pulmonary delivery.
    Klingler C, Müller BW, Steckel H.
    Int J Pharm; 2009 Jul 30; 377(1-2):173-9. PubMed ID: 19446621
    [Abstract] [Full Text] [Related]

  • 19. Ethambutol-Loaded Solid Lipid Nanoparticles as Dry Powder Inhalable Formulation for Tuberculosis Therapy.
    Nemati E, Mokhtarzadeh A, Panahi-Azar V, Mohammadi A, Hamishehkar H, Mesgari-Abbasi M, Ezzati Nazhad Dolatabadi J, de la Guardia M.
    AAPS PharmSciTech; 2019 Feb 22; 20(3):120. PubMed ID: 30796625
    [Abstract] [Full Text] [Related]

  • 20. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
    Sheshala R, Peh KK, Darwis Y.
    Drug Dev Ind Pharm; 2009 Nov 22; 35(11):1364-74. PubMed ID: 19832637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.